Heteroaromatic compounds and their use as dopamine D1 ligands
First Claim
Patent Images
1. A method for treating a D1-associated disease or disorder in a mammal, which method comprises administering to the mammal a therapeutically effective amount of a compound of Formula I:
0 Assignments
0 Petitions
Accused Products
Abstract
The present invention provides, in part, compounds of Formula I:
and pharmaceutically acceptable salts thereof; processes for the preparation of; intermediates used in the preparation of; and compositions containing such compounds or salts, and their uses for treating D1-mediated (or D1-associated) disorders including, e.g., schizophrenia (e.g., its cognitive and negative symptoms), cognitive impairment (e.g., cognitive impairment associated with schizophrenia, AD, PD, or pharmacotherapy therapy), and Parkinson'"'"'s disease.
-
Citations
13 Claims
- 1. A method for treating a D1-associated disease or disorder in a mammal, which method comprises administering to the mammal a therapeutically effective amount of a compound of Formula I:
Specification